KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:RXII
Delisted

RXI Pharmaceuticals Corporation Fund Predictions

$0.82
+0 (+0%)
At Close: Dec 08, 2023
Currently predicting for Mon, 29 Apr 2024

RXII Predictions History

4 years ago
NameNotImportant predicted that RXII for 2019-05-06 is going $0.493 (1.65%)

5 years ago
JS predicted that RXII for 2018-11-15 is going $0.285 (-13.64%)

5 years ago
See.Oh.Si-melee.91870 predicted that RXII for 2018-11-15 is going $0.310 (-6.06%)

Rank:

5 years ago
JS predicted that RXII for 2018-07-11 is going $2.17 (8.50%)

5 years ago
JS predicted that RXII for 2018-05-04 is going $2.41 (-2.03%)

6 years ago
JS predicted that RXII for 2017-07-11 is going $0.658 (-90.34%)

7 years ago
Artur predicted that RXII for 2017-04-17 is going $0.84 (-88.68%)

Rank:

7 years ago
Buckhead predicted that RXII for 2017-04-17 is going $0.620 (-91.64%)

Rank:

7 years ago
JS predicted that RXII for 2017-04-17 is going $0.738 (-90.05%)

7 years ago
JS predicted that RXII for 2017-04-07 is going $0.738 (-90.54%)

Click to get the best stock tips daily for free!

About RXI Pharmaceuticals Corporation

RXi Pharmaceuticals Corporation, a clinical-stage RNAi company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. The company develops therapies based on siRNA technology and immunotherapy agents. Its clinical development programs include RXI-109, a self-delivering RNAi compound, which is in Phase IIa clinical trial that is used to prevent or reduce dermal scarring following surgery or trauma... RXII Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT